Wayne State University School of Medicine, Detroit, Michigan, USA.
Department of Dermatology, Wayne State University, Detroit, Michigan, USA.
J Cosmet Dermatol. 2024 Jul;23(7):2328-2344. doi: 10.1111/jocd.16278. Epub 2024 Mar 12.
Eyelash serums, both prescription and over-the-counter, are gaining popularity for enhancing the appearance of eyelashes through various biologically active molecules. Categorized into prostaglandin analogs and non-prostaglandin analogs, these serums claim increased strength, length, luster, and thickness. Current United States law also requires no efficacy or safety assessments by the Food and Drug Administration before approving products for consumer use, potentially posing health risks for patients seeking over-the-counter eyelash enhancements.
Our aims include exploring proposed benefits and adverse effects associated with eyelash serums, while providing evidence-based clinical recommendations on their use. We aim to contribute valuable insights to the understanding of eyelash serums and their respective safety considerations.
The authors conducted a comprehensive electronic search across databases including PubMed, Embase, Cochrane Central, and Google Scholar to evaluate eyelash serum ingredients. Articles were evaluated by two independent researchers for relevance, and the ingredients discussed were analyzed and given clinical recommendations for eyelash serums based off the Oxford Centre for Evidence-Based Medicine.
Results highlight bimatoprost's efficacy, supported by numerous studies evaluating safety and adverse effects. Other prostaglandin ingredients show potential benefits, but further studies are encouraged to enhance the understanding of respective safety profiles. While non-prostaglandins ingredients show promising data, more studies are needed due to a lack of formal evidence in eyelash serum use.
As the cosmeceutical market for eyelash serums is growing, dermatologists need to be knowledgeable about evidence-based information regarding prescription and over-the-counter eyelash serum products before making recommendations to patients.
睫毛液,包括处方和非处方,通过各种生物活性分子来增强睫毛的外观,越来越受到欢迎。这些睫毛液分为前列腺素类似物和非前列腺素类似物,声称能增强睫毛的强度、长度、光泽和厚度。目前,美国法律在批准产品供消费者使用之前,不需要食品和药物管理局对其进行疗效或安全性评估,这可能会给寻求非处方睫毛增强的患者带来健康风险。
我们的目的包括探索与睫毛液相关的益处和不良反应,并提供关于其使用的循证临床建议。我们旨在为理解睫毛液及其各自的安全考虑提供有价值的见解。
作者通过对 PubMed、Embase、Cochrane 中心和 Google Scholar 等数据库进行全面的电子检索,评估了睫毛液的成分。由两名独立的研究人员评估文章的相关性,根据牛津循证医学中心对讨论的成分进行分析,并为睫毛液提供临床建议。
结果突出了比马前列素的疗效,大量研究评估了其安全性和不良反应。其他前列腺素成分显示出潜在的益处,但鼓励进行更多的研究,以增强对各自安全概况的理解。虽然非前列腺素成分显示出有希望的数据,但由于缺乏在睫毛液使用方面的正式证据,需要进行更多的研究。
随着睫毛液的美容市场不断增长,皮肤科医生在向患者提出建议之前,需要了解有关处方和非处方睫毛液产品的循证信息。